本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Ascendis Pharma A/S

159.71
+1.570.99%
成交量:26.73万
成交额:4,228.46万
市值:96.03亿
市盈率:-23.62
高:161.02
开:159.47
低:155.54
收:158.14
数据加载中...
2019/08/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/10

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/07/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/26

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/18

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/06/10

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/30

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/16

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/05/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/19

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/12

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/04/03

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/14

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/12

超过5%披露

[Amend] General statement of acquisition of beneficial ownership
2019/03/08

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/04

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]
2019/03/01

非美公司披露报告

Report of foreign issuer [Rules 13a-16 and 15d-16]